Comparison of the MMP-3 ratio between the DAS and US remission groups and the non-remission groups.
- Nao Tokai (5680382)
- Shuzo Yoshida (525805)
- Takuya Kotani (525802)
- Ayaka Yoshikawa (5680385)
- Yuko Kimura (525806)
- Youhei Fujiki (5680388)
- Yoko Matsumura (4267228)
- Tohru Takeuchi (525801)
- Shigeki Makino (525807)
- Shigeki Arawaka (525081)
Publication date
August 2018
DOI Publisher
Public Library of Science (PLoS)Abstract
MMP-3 ratio, ratio of the serum matrix metalloproteinase 3 levels at baseline to those at 12 weeks; DAS remission, disease activity score in 28 joints <2.6; US remission, total power Doppler ultrasound score <3.</p
Add to ORKG